miR-1258, a tumor suppressor downregulated in OSCC cells and tissues, was demonstrated to prevent proliferation and EMT phenotype in OSCC by targeting SP1 and the PI3K/AKT and ERK signaling pathways. This evidence concerns the gene AKT1 and neoplasm.